Cancer drugs

These companies develop or sell medicines that treat cancer, such as pills, antibodies and cell therapies.
+15.1%
over 3 months · S&P 500 −2.1%

Key indicators

Health
49 / 100
Fragile
Solid
Price
P/E 40
Cheap
Expensive
Up over 1 year
57 of 105
Wallets over 90 days
2 / 5 buys / sells
Buys
Sells
Health and price: against the other tags.

The 113 companies

LLY
+22.0%
JNJ
+9.4%
ABBV
+17.9%
MRK
Size: weight in the tag. Color: move over the period.
See all companies
L
Eli Lilly
LLY
33.3%
+22.0%
J
Johnson & Johnson
JNJ
16.5%
+9.4%
A
AbbVie
ABBV
12.9%
+17.9%
M
Merck
MRK
9.0%
+9.3%
A
Amgen
AMGN
6.2%
+11.7%
G
Gilead Sciences
GILD
5.2%
+21.7%
P
Pfizer
PFE
4.1%
+9.1%
B
Bristol-Myers Squibb
BMY
3.1%
−0.8%
R
Regeneron Pharmaceuticals
REGN
2.3%
+18.7%
M
Moderna
MRNA
2.2%
+246.5%
R
Revolution Medicines
RVMD
1.1%
−18.7%
I
Incyte
INCY
0.6%
−2.0%
E
Exelixis
EXEL
0.4%
+31.9%
S
Summit Therapeutics
SMMT
0.3%
+10.7%
C
Corcept Therapeutics
CORT
0.2%
−37.7%
I
ImmunityBio
IBRX
0.2%
−24.0%
C
CG Oncology
CGON
0.2%
−3.5%
E
Erasca
ERAS
0.1%
−14.3%
C
Cogent Biosciences
COGT
0.1%
−24.6%
L
Legend Biotech
LEGN
<0.1%
−15.3%
R
Relay Therapeutics
RLAY
<0.1%
−12.5%
T
Tango Therapeutics
TNGX
<0.1%
+0.8%
E
Enliven Therapeutics
ELVN
<0.1%
−18.0%
I
Iovance Biotherapeutics
IOVA
<0.1%
+9.3%
P
Parabilis Medicines
PBLS
<0.1%
−23.6%
C
Celcuity
CELC
<0.1%
−30.4%
I
IDEAYA Biosciences
IDYA
<0.1%
−12.9%
X
Xencor
XNCR
<0.1%
+60.4%
R
Arcus Biosciences
RCUS
<0.1%
−41.0%
B
Biohaven
BHVN
<0.1%
−4.4%
I
Immunome
IMNM
<0.1%
−31.5%
R
Recursion Pharmaceuticals
RXRX
<0.1%
+2.4%
R
Replimune Group
REPL
<0.1%
+49.6%
V
Vir Biotechnology
VIR
<0.1%
+6.1%
Z
Zymeworks
ZYME
<0.1%
+3.7%
S
SELLAS Life Sciences
SLS
<0.1%
−39.5%
P
Precigen
PGEN
<0.1%
−30.7%
N
Nurix Therapeutics
NRIX
<0.1%
−43.0%
N
Nuvation Bio
NUVB
<0.1%
−38.4%
T
Tyra Biosciences
TYRA
<0.1%
−23.6%
D
Damora Therapeutics
DMRA
<0.1%
−30.5%
I
Inhibrx
INBX
<0.1%
−9.5%
V
Verastem
VSTM
<0.1%
+13.9%
C
Corvus Pharmaceuticals
CRVS
<0.1%
−28.6%
A
Aktis Oncology
AKTS
<0.1%
−32.8%
O
Oric Pharmaceuticals
ORIC
<0.1%
−41.3%
S
Syndax Pharmaceuticals
SNDX
<0.1%
−52.2%
R
Rigel Pharmaceuticals
RIGL
<0.1%
+4.7%
O
Obsidian Therapeutics
OBX
<0.1%
−28.4%
A
Aura Biosciences
AURA
<0.1%
−7.4%
S
Sana Biotechnology
SANA
<0.1%
−45.1%
C
Cullinan Therapeutics
CGEM
<0.1%
−50.1%
F
Fulgent Genetics
FLGT
<0.1%
+32.2%
N
Nuvectis Pharma
NVCT
<0.1%
+6.1%
D
Delcath Systems
DCTH
<0.1%
+20.5%
K
Kura Oncology
KURA
<0.1%
−31.1%
C
Candel Therapeutics
CADL
<0.1%
−49.0%
O
Olema Pharmaceuticals
OLMA
<0.1%
−29.8%
J
Janux Therapeutics
JANX
<0.1%
−30.1%
B
Bicara Therapeutics
BCAX
<0.1%
−59.8%
A
ArriVent BioPharma
AVBP
<0.1%
−55.2%
G
Geron
GERN
<0.1%
−36.8%
C
Crescent Biopharma
CBIO
<0.1%
−19.1%
M
Monopar Therapeutics
MNPR
<0.1%
−38.2%
C
CytomX Therapeutics
CTMX
<0.1%
−40.9%
B
BlossomHill Therapeutics
BLSM
<0.1%
−14.4%
A
Arvinas
ARVN
<0.1%
−25.9%
R
Relmada Therapeutics
RLMD
<0.1%
−11.7%
P
Puma Biotechnology
PBYI
<0.1%
−11.9%
C
C4 Therapeutics
CCCC
<0.1%
−35.3%
F
Faeth Therapeutics
FTH
<0.1%
−69.4%
E
Eikon Therapeutics
EIKN
<0.1%
−42.9%
A
Agenus
AGEN
<0.1%
−5.9%
A
Allogene Therapeutics
ALLO
<0.1%
−59.7%
I
Immuneering
IMRX
<0.1%
−28.9%
C
Cypherpunk Technologies
CYPH
<0.1%
+165.1%
Z
Zentalis Pharmaceuticals
ZNTL
<0.1%
−54.1%
S
Sutro Biopharma
STRO
<0.1%
−55.9%
A
ALX Oncology
ALXO
<0.1%
−47.2%
F
Fate Therapeutics
FATE
<0.1%
−51.1%
I
Inovio Pharmaceuticals
INO
<0.1%
+24.3%
P
PDS Biotechnology
PDSB
<0.1%
+295.7%
C
Perspective Therapeutics
CATX
<0.1%
−70.7%
C
Corbus Pharmaceuticals
CRBP
<0.1%
−67.7%
A
Acrivon Therapeutics
ACRV
<0.1%
−29.3%
A
ABVC BioPharma
ABVC
<0.1%
+7.1%
A
Actuate Therapeutics
ACTU
<0.1%
−71.2%
A
Allarity Therapeutics
ALLR
<0.1%
−28.8%
A
AIM ImmunoTech
AIM
<0.1%
−40.9%
B
BioAtla
BCAB
<0.1%
−43.3%
A
Ascentage Pharma Group International
AAPG
−19.7%
A
Adagene
ADAG
−55.4%
A
ADC Therapeutics
ADCT
+21.8%
A
Adlai Nortye
ANL
−20.5%
A
Autolus Therapeutics
AUTL
−48.7%
A
AstraZeneca
AZN
+17.6%
B
BioNTech
BNTX
−6.6%
E
Electra Therapeutics
ETRA
G
Genmab
GMAB
+56.4%
G
GSK
GSK
+0.3%
H
HUTCHMED
HCM
+18.6%
I
Iambic Therapeutics
IAM
I
Immunocore
IMCR
−14.6%
I
Immatics
IMTX
−30.9%
J
Jazz Pharmaceuticals
JAZZ
−2.7%
N
Nanobiotix
NBTX
−27.1%
N
Novartis
NVS
+5.6%
O
BeOne Medicines
ONC
+14.9%
R
Roche Holdings
RHHBY
0.0%
T
Takeda Pharmaceutical
TAK
+23.3%
T
Telix Pharmaceuticals
TLX
−21.3%
U
UroGen Pharma
URGN
−46.7%
Z
Zai Lab
ZLAB
−4.1%